All research papers
2996 approved papers, newest first · showing 901–960.Search instead →
- 5 Aug 2026· Physics in medicine and biology· Adaptive radiotherapy· QA & dosimetry· Free full textImproved synthetic CT image quality does not guarantee dosimetric agreement in CBCT-based adaptive proton radiotherapy.Yeap PL et al.
- 5 Aug 2026· Physics in medicine and biology· Adaptive radiotherapy· QA & dosimetry· Free full textDecoupling the dosimetric impact of setup errors and anatomical deformations in image-guided radiotherapy using diagnostic-quality FBCT and glmmLasso regularization.Zhao L et al.
- 5 Aug 2026· Physics in medicine and biology· Adaptive radiotherapy· QA & dosimetry· Free full textReconstructing delivered dose in real time: a beam physics-embedded, language-model-driven approach.Wang Y et al.
- 5 Aug 2026· BMC medical imaging· Adaptive radiotherapy· Therapeutic· QA & dosimetryOnline adaptive radiotherapy in pelvic and thoracic cancers - comparing toxicities, clinical outcomes and technical parameters between conventional image-guided radiotherapy and online adaptive radiotherapy - the study protocol for the prospective, registry-based cohort study (PRoART).Fischer LA et al.
- 5 Aug 2026· AJNR. American journal of neuroradiology· SRS / intracranial· DiagnosticArterial Spin Labeling-Derived Fractional Tumor Burden as a Primary Biomarker for Differentiating Recurrent Tumor from Radiation Necrosis After Stereotactic Radiosurgery.Christodoulou R et al.
- 5 Aug 2026· Physics in medicine and biology· Patient-specific QA· QA & dosimetryA deep learning framework for radiotherapy dose prediction: from MLC motion to patient-specific dose perturbation.Chen L et al.
- 5 Aug 2026· Physics in medicine and biology· Linac QA· QA & dosimetry· Free full textAnalytical convolution/superposition modelling of one-dimensional dose profiles with asymmetric energy deposition kernels in homogeneous media.Pisaturo O et al.
- 5 Aug 2026· European journal of nuclear medicine and molecular imaging· Ga-68 DOTATATE· DiagnosticGenotype-location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas.Imperiale A et al.
- 5 Aug 2026· European journal of nuclear medicine and molecular imaging· Ga-68 DOTATATE· Theranostic· TherapeuticTumour-absorbed dose and efficacy of peptide receptor radionuclide therapy with [⁹⁰Y]Y-DOTATOC in patients with refractory meningioma: a single-centre experience.Schweiger L et al.
- 5 Aug 2026· Nuclear medicine communications· Ga-68 PSMA PET· Diagnostic68Ga prostate-specific membrane antigen PET/computed tomography in benign and malignant prostatic lesions: a study of maximum standardized uptake value and uptake patterns with clinicopathological correlation.Mangale P et al.
- 4 Aug 2026· Radiotherapy and oncology· Adaptive radiotherapy· TherapeuticEarly regression index-guided adaptive dose escalation in locally advanced rectal cancer: results of the prospective THUNDER-2 trial.Chiloiro G et al.
- 4 Aug 2026· Radiotherapy and oncology· Adaptive radiotherapy· TherapeuticTemporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol.Canters R et al.
- 4 Aug 2026· Clinical nuclear medicine· Ga-68 PSMA PET· TherapeuticMultimodal Management of Advanced Metastatic Prostate Cancer: Excellent Response Following Resection of Brain Metastasis and 177Lu-PSMA Therapy.Divband G et al.
- 4 Aug 2026· Journal of imaging informatics in medicine· DiagnosticEarly Follicular Lymphoma Grading via PET-CT Fusion and Bayesian Deep Learning.Qian C et al.
- 4 Aug 2026· Zeitschrift fur medizinische Physik· QA & dosimetryPerformance evaluation of the Biograph Trinion EP2 PET/CT system according to NEMA NU2-2018.Rausch I et al.
- 4 Aug 2026· Research (Washington, D.C.)· DiagnosticA New Fluorine-18-Fluoroethyltyrosine Positron-Emission-Tomography/Magnetic-Resonance-Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study.Cheng Y et al.
- 4 Aug 2026· Nuclear medicine communications· TheranosticEvolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis.Jia YN et al.
- 4 Aug 2026· Nuclear medicine communications· Ga-68 PSMA PET· DiagnosticAssociation of prostate-specific antigen kinetics with gallium-68 prostate-specific membrane antigen PET/computed tomography positivity in biochemical recurrence after radical prostatectomy.Nuthalapati M et al.
- 4 Aug 2026· Nuclear medicine communications· Lu-177 DOTATATE· TherapeuticEfficacy of intra-arterial [ 177 Lu]Lu-DOTATATE vs. continuation intravenous [ 177 Lu]Lu-DOTATATE peptide receptor radionuclide therapy in nonresponding locally advanced inoperable or liver-dominant metastatic gastroenteropancreatic neuroendocrine tumors.Bagasariya R et al.
- 4 Aug 2026· Journal of nuclear medicine technology· Radiation safetyPreparing for Practice, Part 2: A Simulation-Based Curriculum Framework for Radiopharmaceutical Therapy Education-A Program Improvement Initiative.Bolin JD.
- 4 Aug 2026· EJNMMI radiopharmacy and chemistry· RadiopharmacyStable core-encapsulation of indium-111 in crosslinked polyionic complex micelles and assessment of its biodistribution.Mizuno HL et al.
- 4 Aug 2026· Biomedical physics & engineering express· Gold-anchor fiducial markers· QA & dosimetryQuantifying daily residual motion of bilateral diaphragmatic domes using an iterative detection algorithm for breath-hold radiation therapy.Wei J et al.
- 4 Aug 2026· Journal of neuro-oncology· SRS / intracranial· TherapeuticBrain metastases in triple-negative breast cancer: a systematic review of current trends, treatment strategies, and outcomes.Begagić E et al.
- 4 Aug 2026· Journal of neuro-oncology· SRS / intracranial· TherapeuticThe risk of sinus vein thrombosis in patients treated with intraoperative radiotherapy for sinus adjacent tumours.Bakos J et al.
- 4 Aug 2026· Physical and engineering sciences in medicine· Adaptive radiotherapy· QA & dosimetryPancreas SBRT requires online adaptive treatment to adequately manage motion.Young T et al.
- 3 Aug 2026· Clinical nuclear medicine· Lu-177 DOTATATE· TherapeuticCombination Treatment Strategies With Peptide Receptor Radionuclide Therapy: The Current Status and Potential Future Applications in Theranostics of Neuroendocrine Tumors.Parghane RV et al.
- 3 Aug 2026· Healthcare (Basel, Switzerland)· Personal / occupational dosimetry· Radiation safety· Free full textRadiation Safety Knowledge, Perceptions, and Self-Reported Practices Among Healthcare Workers in Radiology and Nuclear Medicine: A Cross-Sectional Survey.Pepele EK et al.
- 3 Aug 2026· Clinical and translational radiation oncology· Adaptive radiotherapy· Therapeutic· QA & dosimetry· Free full textWorkflow and dosimetric results for direct-to-unit single-fraction adaptive lung SBRT delivered on the ONE-STOP prospective pilot clinical trial.Forghani F et al.
- 3 Aug 2026· Clinical neurology and neurosurgery· SRS / intracranial· TherapeuticClinical utility of early MRI follow-up after radiosurgery for solitary meningiomas: A single center, retrospective analysis.Bailey D et al.
- 3 Aug 2026· Molecular pharmaceutics· Ac-225 alpha therapy· Therapeutic· Free full textMacropa-Based 225Ac-Labeled RGD Peptides for Targeted Alpha Therapy.Echigo H et al.
- 3 Aug 2026· Cancer treatment and research communications· SBRT delivery· TherapeuticRadiotherapy strategies for prostate cancer: Techniques, outcomes, and patient care.Khalaji A et al.
- 3 Aug 2026· Actas urologicas espanolas· SBRT delivery· TherapeuticReal-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival.Samper Ots PM et al.
- 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Ac-225 alpha therapy· TherapeuticDosimetry Results from the Phase 1b/3 ACTION-1 Trial of [²²⁵Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs.Sgouros G et al.
- 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Ga-68 PSMA PET· DiagnosticDiagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing ⁶⁸Ga-PSMA PET/CT.Jia KY et al.
- 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 DOTATATE· TherapeuticNephron-Level Dosimetry Reveals Increased Absorbed Dose Heterogeneity of ¹⁶¹Tb- Versus ¹⁷⁷Lu-DOTATATE in Murine Kidneys Despite Similar Pharmacokinetics.Andersson M et al.
- 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 PSMA· TherapeuticThrombotic Microangiopathy in Patients Treated with ¹⁷⁷Lu-PSMA Combination Therapies.Chan JC et al.
- 3 Aug 2026· Physics in medicine and biology· OSL dosimetry· QA & dosimetryEvaluation of skin dose robustness in breast radiotherapy using VMAT planning technique: a phantom-based surface dosimetry study.Yoo D et al.
- 3 Aug 2026· Thyroid : official journal of the American Thyroid Association· DiagnosticPrognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.Prinzi A et al.
- 3 Aug 2026· Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico· SBRT delivery· QA & dosimetry· TherapeuticIntermediate rectal dose is associated with late toxicity after prostate SBRT: a dose-volume histogram principal component analysis.Zurita AJW et al.
- 2 Aug 2026· The Prostate· Ga-68 PSMA PET· DiagnosticManagement of De Novo miN1 Prostate Cancer in the PSMA-PET Era.McMaster T et al.
- 2 Aug 2026· Scientific reports· DiagnosticDetection of lung cancer using Kronecker mobile forward harmonic net.Prasad JR et al.
- 1 Aug 2026· Molecular pharmaceutics· Cyclotron production· Radiopharmacy· DiagnosticAutomated Radiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models and Nonhuman Primates.Ye W et al.
- 1 Aug 2026· Journal of medicinal chemistry· Lu-177 PSMA· TherapeuticPSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.Qi X et al.
- 1 Aug 2026· Journal of labelled compounds & radiopharmaceuticals· Cyclotron production· Radiopharmacy· DiagnosticReliable One-Pot Automated Preparation of [<sup>11</sup>C]SL25.1188 for Use in Clinical Imaging Studies.Hashimoto H et al.
- 1 Aug 2026· Journal of labelled compounds & radiopharmaceuticals· Cyclotron production· Radiopharmacy· DiagnosticA Practical Radiosynthesis of (S)-[<sup>11</sup>C]SMBT-1 for MAO-B PET Imaging.Akula HK et al.
- 1 Aug 2026· Journal of labelled compounds & radiopharmaceuticals· Cyclotron production· Radiopharmacy· DiagnosticSimple and Efficient Automated Radiosynthesis of 1-[<sup>18</sup>F]-IPA Using Solid-Phase Extraction Cartridges Purification.Dong W et al.
- 1 Aug 2026· Radiation protection dosimetry· OSL dosimetry· Radiation safetyAI-driven triage classification at the 1 Gy threshold using dietary supplements and portable OSL dosimetry.Della Monaca S et al.
- 1 Aug 2026· Medical physics· Ac-225 alpha therapy· TherapeuticAn analytical framework for efficient and precision-controlled Monte Carlo simulation of heterogeneous targeted alpha therapy microdosimetry.Zhu J et al.
- 1 Aug 2026· Journal of applied clinical medical physics· SBRT delivery· QA & dosimetry· Free full textA geometry-based scaling model for stereotactic treatment volume definition in stereotactic centralized ablative radiation therapy.Siah N et al.
- 1 Aug 2026· Radiation protection dosimetry· Personal / occupational dosimetry· Radiation safetyMailed dose record review of occupational dosimetry records among Japanese medical radiation workers: the OREMS Study.Kitamura H et al.
- 1 Aug 2026· Medical physics· TLD dosimetry· QA & dosimetry· Free full textLighting up FLASH and beyond: TLD response across four orders of magnitude in proton dose rate.Guan F et al.
- 1 Aug 2026· Journal of applied clinical medical physics· Gold-anchor fiducial markers· QA & dosimetry· Free full textImpact of MRI slice thickness and fiducial marker orientation on geometric accuracy in multi-echo GRE imaging for prostate radiotherapy planning.Hayashi A et al.
- 1 Aug 2026· Journal of applied clinical medical physics· MR-linac / MR-guided· QA & dosimetry· Free full textClinical implementation and performance evaluation of a motorized MR-compatible OCTAVIUS 4D system for SBRT patient-specific QA on a 1.5 T MR-LINAC.Chevillard C et al.
- 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetryHyperSight CBCT dose calculation accuracy for adaptive head and neck radiotherapy: Results from a prospective clinical trial.Yashayaeva A et al.
- 1 Aug 2026· Cancer medicine· SRS / intracranial· TherapeuticUp to Four-Year Outcomes of Single-Fraction Stereotactic Radiosurgery for Small Brain Metastases: A Competing-Risk Analysis.Gruber I et al.
- 1 Aug 2026· Journal of applied clinical medical physics· Linac QA· QA & dosimetryCommissioning and clinical positioning assessment of a novel surface-guided radiation therapy (SGRT) system at a C-Arm linear accelerator.Looe HK et al.
- 1 Aug 2026· Neuro-oncology· SRS / intracranial· TherapeuticIntracranial progression-free survival correlates with overall survival and varies by tumor subtype in patients with breast cancer and brain metastases.Sammons SL et al.
- 1 Aug 2026· Neuro-oncology· Ac-225 alpha therapy· TherapeuticRadiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy.Zhao L et al.
- 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetryEquivariant conditional diffusion model for head and neck CT image synthesis from CBCT.Altalib A et al.
- 1 Aug 2026· Journal of applied clinical medical physics· MR-linac / MR-guided· QA & dosimetryImage-based evaluation of a commercial AI synthetic CT generator for brain and prostate MR-only radiotherapy.Aire M et al.